December 12, 2016 by Geoff Walden and Chain Drug Review
ACA, Affordable Care Act, Centers for Medicare & Medicaid Services, CMS, Department of Health and Human Services, Donald Trump, HHS, National Association of Chain Drug Stores, Obamacare, Seema Verma, Steve Anderson, Tom Price
2016, Issue 12-12-2016, Issues, Leading Headlines, News, Pharmacy, Retail News
WASHINGTON — The choices of Tom Price and Seema Verma for top health positions under Donald Trump have reaffirmed the president-elect’s commitment to toppling the Affordable Care Act. Price, a six-term Republican congressman from Georgia and fierce critic of Obamacare, was picked as secretary of the Department of Health and Human Services (HHS), while Verma,
November 30, 2016 by Chain Drug Review
Affordable Care Act, Centers for Medicare & Medicaid Services, CMS adminstrator, Donald Trump, HHS secretary, NACDS, National Association of Chain Drug Stores, Seema Verma, Steve Anderson, Tom Price, U.S. Department of Health and Human Services
Featured Articles, Leading Headlines, Pharmacy, Retail News
ARLINGTON, Va. — The National Association of Chain Drug Stores said it’s ready to work with President-elect Donald Trump’s nominees to lead the U.S. Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS). Trump on Tuesday named U.S. Rep. Tom Price (R., Ga.) as HHS secretary and Seema
November 21, 2016 by Geoff Walden and Chain Drug Review
Affordable Care Act, Donald Trump, health insurance, Mitch McConnell, Obamacare, Paul Ryan, Restoring Americans’ Healthcare Freedom Reconciliation Act of 2015
2016, Issue 11-21-2016, Issues, Leading Headlines, News, Pharmacy, Retail News
WASHINGTON — If Obamacare is repealed, what will replace it? That is the question in the aftermath of the election of Donald Trump as president. Trump has vowed to “repeal and replace” the Affordable Care Act as his first act in office. If the effort succeeds, some 22 million fewer Americans would have health insurance,
November 7, 2016 by Geoff Walden and Chain Drug Review
ACA, Affordable Care Act, Avalere Health, Barack Obama, Caroline Pearson, Department of Health and Human Services, Donald Trump, health insurance exchange, HealthCare.gov, Hillary Clinton, Kaiser Family Foundation, Larry Levitt, Obamacare, Orrin Hatch, Sylvia Burwell
2016, Issue 11-07-2016, Issues, News
WASHINGTON — Premiums for health plans purchased through the Affordable Care Act will rise sharply next year, and insurer defections in some states will leave consumers with substantially fewer coverage options, the federal government reported. Premiums will increase, on average, 25% for mid-level plans on the federal health insurance exchange, according to the Department of
October 19, 2016 by Geoff Walden and Chain Drug Review
2016 presidential election, ACA, Affordable Care Act, Donald Trump, health care, health insurance, Hillary Clinton, Obamacare
Featured Articles, Issue 10-24-2016, Leading Headlines, News, Pharmacy, Retail News
WASHINGTON — Change is apparently looming for the Affordable Care Act, regardless of whether Hillary Clinton or Donald Trump wins the 2016 presidential election. Though it’s uncertain if health care will emerge as a topic at tonight’s third and final presidential debate in Las Vegas at the University of Nevada, the issue was the subject
September 26, 2016 by Greg Jacobson and Chain Drug Review
2016 presidential election, Affordable Care Act, Donald Trump, drug pricing, generic drugs, health care, Hillary Clinton, prescription drug costs
2016, Business, Issue 09-26-2016, Issues, Leading Headlines, News, Retail News
NEW YORK — With the 2016 presidential election drawing near, health care has emerged as a policy area in which the two major candidates’ differences are strikingly clear. A useful starting point might be their respective approaches to prescription drug pricing. The Republican candidate, Donald Trump, created a sensation in January when he advocated allowing
September 26, 2016 by Jeffrey Woldt and Chain Drug Review
2016 presidential election campaign, Affordable Care Act, Donald Trump, HealthCare.gov, Hillary Clinton, Jeffrey Woldt
2016, Issue 09-26-2016, Issues, Opinion
One of the more surprising aspects of the sad spectacle leading up to the election of a new president and new Congress in November is the lack of serious, sustained debate about health care. When the Patient Protection and Affordable Care Act was signed into law by President Obama in March 2010, the nation embarked